Zarir Udwadia
Overview
Explore the profile of Zarir Udwadia including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
47
Citations
956
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dheda K, Mirzayev F, Cirillo D, Udwadia Z, Dooley K, Chang K, et al.
Nat Rev Dis Primers
. 2024 Mar;
10(1):22.
PMID: 38523140
Tuberculosis (TB) remains the foremost cause of death by an infectious disease globally. Multidrug-resistant or rifampicin-resistant TB (MDR/RR-TB; resistance to rifampicin and isoniazid, or rifampicin alone) is a burgeoning public...
2.
Spagnolo P, Ryerson C, Guler S, Feary J, Churg A, Fontenot A, et al.
J Intern Med
. 2023 Aug;
294(6):798-815.
PMID: 37535448
Millions of workers are exposed to substances known to cause occupational interstitial lung diseases (ILDs), particularly in developing countries. However, the burden of the disease is likely to be underestimated...
3.
Motta I, Boeree M, Chesov D, Dheda K, Gunther G, Horsburgh Jr C, et al.
Clin Microbiol Infect
. 2023 Jul;
30(9):1107-1114.
PMID: 37482332
Background: Tuberculosis (TB) is a global health challenge and one of the leading causes of death worldwide. In the last decade, the TB treatment landscape has dramatically changed. After long...
4.
Masini T, Furin J, Udwadia Z, Guglielmetti L
Indian J Med Res
. 2023 May;
157(2&3):220-222.
PMID: 37202941
No abstract available.
5.
Rajan S, Cottin V, Dhar R, Danoff S, Flaherty K, Brown K, et al.
Eur Respir J
. 2022 Dec;
61(3).
PMID: 36517177
This expert group consensus statement emphasises the need for standardising the definition of progressive fibrosing interstitial lung diseases (F-ILDs), with an accurate initial diagnosis being of paramount importance in ensuring...
6.
Nilgiriwala K, Kadam P, Patel G, Shaikh A, Mestry T, Vaswani S, et al.
J Med Virol
. 2022 May;
94(9):4206-4215.
PMID: 35578378
The present study was initiated to understand the proportion of predominant variants of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) in postvaccination infections during the Delta dominated second wave of...
7.
Campbell J, Chan E, Falzon D, Trajman A, Keshavjee S, Leung C, et al.
Clin Infect Dis
. 2022 Apr;
75(12):2201-2210.
PMID: 35476134
Background: The impact of low body mass index (BMI) at initiation of rifampicin-resistant tuberculosis (RR-TB) treatment on outcomes is uncertain. We evaluated the association between BMI at RR-TB treatment initiation...
8.
Wijsenbeek M, Lee J, Udwadia Z, Kreuter M
Front Med (Lausanne)
. 2022 Apr;
9:865334.
PMID: 35372425
No abstract available.
9.
Dheda K, Perumal T, Moultrie H, Perumal R, Esmail A, Scott A, et al.
Lancet Respir Med
. 2022 Mar;
10(6):603-622.
PMID: 35338841
The global tuberculosis burden remains substantial, with more than 10 million people newly ill per year. Nevertheless, tuberculosis incidence has slowly declined over the past decade, and mortality has decreased...
10.
Salvi S, Ghorpade D, Dhoori S, Dhar R, Dumra H, Chhajed P, et al.
Lung India
. 2022 Mar;
39(2):177-186.
PMID: 35259802
No abstract available.